Low-dose oral contraceptives in adolescents: how low can you go?
H Agostino, G Di Meglio - Journal of Pediatric and Adolescent Gynecology, 2010 - Elsevier
CONTEXT: The use of combined oral contraception (COC) before the accrual of peak bone
mass in adolescents is common. Despite the tendency to prescribe lower ethinyl estradiol …
mass in adolescents is common. Despite the tendency to prescribe lower ethinyl estradiol …
Hormonal Contraception and Physiology: A Research‐based Theory of Discontinuation Due to Side Effects
VJ Vitzthum, K Ringheim - Studies in family planning, 2005 - Wiley Online Library
Side effects influence the acceptability and continuation of hormonal contraceptives.
Counseling the client about the management of side effects is a principal approach …
Counseling the client about the management of side effects is a principal approach …
Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled …
C Nappi, ADS Sardo, G Acunzo, G Bifulco… - Contraception, 2003 - Elsevier
In this prospective, controlled, randomized study, we compared the effect of a low-dose 21-
day combined oral contraceptive (COC) containing 20 μg ethinyl estradiol (EE) and 75 μg …
day combined oral contraceptive (COC) containing 20 μg ethinyl estradiol (EE) and 75 μg …
Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective …
V Gargano, M Massaro, I Morra, C Formisano… - Contraception, 2008 - Elsevier
BACKGROUND: The effects of a 21-day combined oral contraceptive containing 30 mcg
ethinyl estradiol plus 3 mg drospirenone with a 21-day preparation containing 20 mcg …
ethinyl estradiol plus 3 mg drospirenone with a 21-day preparation containing 20 mcg …
Oral contraceptive use, bone mineral density, and bone turnover markers over 12 months in college-aged females
HC Almstedt, MM Cook, LF Bramble, DV Dabir… - Journal of bone and …, 2020 - Springer
Introduction The purpose of this study was to compare bone mineral density (BMD) and
bone turnover markers between combined oral contraceptive (COC) and non-COC users …
bone turnover markers between combined oral contraceptive (COC) and non-COC users …
[HTML][HTML] Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience
Y Wang, V Nisenblat, L Tao, XY Zhang… - Journal of Gynecologic …, 2019 - ncbi.nlm.nih.gov
Objective To evaluate the effectiveness of oral contraceptive pill (OCP) as therapy for
endometrial hyperplasia (EH) without atypia in reproductive-aged women compared with …
endometrial hyperplasia (EH) without atypia in reproductive-aged women compared with …
A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use
J Endrikat, C Gerlinger, K Plettig, J Wessel… - Gynecological …, 2003 - Taylor & Francis
We aimed to evaluate potential correlation between ovarian activity during use of combined
oral contraceptives and the incidence of intermenstrual bleeding. Data from seven …
oral contraceptives and the incidence of intermenstrual bleeding. Data from seven …
[HTML][HTML] Чистогестагенная имплантационная контрацепция (обзор международных клинических рекомендаций)
ОА Пустотина - Медицинский совет, 2015 - cyberleninka.ru
В статье представлен обзор международных клинических рекомендаций по
чистогестагенной имплантационной контрацепции. Приведены данные об …
чистогестагенной имплантационной контрацепции. Приведены данные об …
[HTML][HTML] Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day …
J Spona, N Binder, K Höschen, W Feichtinger - Fertility and sterility, 2010 - Elsevier
OBJECTIVE: To describe the suppression of ovarian function with 0.02 mg ethinyl E2–2 mg
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
chlormadinone acetate administered in a 24/4-day intake regimen in healthy women …
Systematic review of ovarian activity and potential for embryo formation and loss during the use of hormonal contraception
D Harrison, C Buskmiller, M Chireau… - The Linacre …, 2018 - journals.sagepub.com
The purpose of this review was to determine whether there is evidence that ovulation can
occur in women using hormonal contraceptives and whether these drugs might inhibit …
occur in women using hormonal contraceptives and whether these drugs might inhibit …